Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, RCT Evaluating the Safety and Hemostatic Effectiveness of SURGICEL Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding During Surgery in Chinese Adult Subjects

NCT03783039 is registered in ClinicalTrials.gov with Ethicon, LLC as lead sponsor.

NCT NCT03783039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03783039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, RCT Evaluating the Safety and Hemostatic Effectiveness of SURGICEL Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding During Surgery in Chinese Adult Subjects
Lead sponsor
Ethicon, LLC
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2019
Completion date
May 6, 2020
Enrollment
234 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage